A program to empower community health workers to combat vaccine misinformation

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Dime La VerDAD is a social media capacity-building initiative designed to empower promotores de salud from the Hispanic community to effectively debunk vaccine misinformation using personal narratives. The program focuses on enhancing the training and self-efficacy of these trusted community members, enabling them to leverage their existing relationships to disseminate accurate health information. Utilizing a mixed methods approach and a stepped wedge design, the study aims to understand and address the impact of misinformation on vaccination rates, particularly in minoritized communities. By fostering communication strategies that emphasize community engagement, the program seeks to improve vaccine confidence and access.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. 18 years or older
2. Fluent in English or Spanish
3. Provide services as a community health worker or similar designation in at least one of the seven communities with high morbidity and mortality due to respiratory virus infections
4. Have a social media presence (personal or work related)

Exclusion Criteria:

1. Plan to stop working as a community health worker or similar designation before spring of 2028 (end of data collection planned)
2. Do not wish to participate in a social media campaign

Where it's running

• University of Chicago
  Chicago, Illinois, United States Recruiting
• Rush University
  Chicago, Illinois, United States Active not recruiting
• University of Iowa
  Iowa City, Iowa, United States Active not recruiting
• University of Michigan
  Ann Arbor, Michigan, United States Active not recruiting

Study contacts

• Principal investigator: Marina DelRios, MD — University of Chicago - Section of Emergency Medicine
• Study coordinator: Yajaira Bolanos Flores, MPH
• Email: Yajaira.BolanosFlores@bsd.uchicago.edu
• Phone: 773-571-0613

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Comparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) in Adults

  This study tests and compares the immune responses and tolerability of the latest COVID-19 vaccines from Novavax and Pfizer/BioNTech in adults at risk for severe COVID-19.

  Recruiting Phase 4 Henry M. Jackson Foundation for the Advancement of Military Medicine · Bethesda, Maryland · NCT07287137

• Virological Monitoring of Seasonal Respiratory Infections in France

  This project tests how often common respiratory viruses show up in patients seen by primary care doctors in metropolitan France during the fall and winter.

  Recruiting Institut National de la Santé Et de la Recherche Médicale, France · Paris · NCT07599449

• Understanding how brain changes relate to smell disorders over time

  This small, year-long study tests how brain activity and smell-related inflammation relate to different smell disorders in adults.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07149428

• Monitoring and detection of influenza, RSV, and COVID-19 in adults with and without HIV in Lusaka

  This project will test methods to detect influenza, RSV, and COVID-19 in adults with and without HIV who have recent respiratory symptoms in Lusaka.

  Recruiting at 2 sites Centre for Infectious Disease Research in Zambia · Lusaka, Lusaka Province and 1 other locations · NCT07030075

• Evaluating COVID-19 and influenza vaccine schedules for immunocompromised individuals

  This study is testing different ways to give COVID-19 and flu vaccines to people with weakened immune systems to see which method works best for their protection.

  Recruiting at 2 sites Phase 2 McGill University Health Centre/Research Institute of the McGill University Health Centre · Montreal, Quebec and 2 other locations · NCT06599658

• Study on influenza and COVID-19 effects in pregnant women in India

  This study is testing how getting both COVID-19 and influenza affects pregnant women and their babies, while also looking at how vaccinations might help reduce risks during pregnancy.

  Recruiting at 2 sites Boston University · Boston, Massachusetts and 1 other locations · NCT06168019

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.